Metacin Valium 2mg 10 pc

Description

Composition
Active substance:
Metotsiniya iodide (metatsina) 2 mg.
Excipients:
Lactose monohydrate (milk sugar), pregelatinized starch, magnesium stearate.
Description:
Round Valium tablets of white or white with a yellowish shade, with a facet and Valium.
Product form:
2 mg tablets.
10 tablets in blisters of PVC film and aluminum foil printed patent. 1 blisters with instructions for use in a cardboard package.
Contraindications
Hypersensitivity, lactase deficiency, lactose intolerance, glucose-galactose malabsorption, children’s age.
Experience in medical use in pediatric patients is not available.
Precautions – disorders of the cardiovascular system, in which an increase in heart rate (HR) may be desirable: atrial fibrillation, tachycardia, congestive heart failure (CHF), coronary heart disease (CHD), mitral stenosis, hypertension, acute bleeding; – fever and febrile symptom (the temperature may even increase due to suppression of the activity of the sweat glands); – reflux esophagitis, hiatal hernia, reflux esophagitis combined with (decreased motility of the esophagus and stomach and lower esophageal sphincter relaxation may help slow gastric emptying and increased gastroesophageal reflux disease); – diseases of the gastrointestinal tract (GIT), accompanied by obstruction achalasia and pyloric stenosis (possibly reduced motility and tone, which leads to obstruction and delay of gastric contents); atony bowel in patients who are elderly or debilitated patients (development of obstruction), paralytic ileus (obstruction may develop); – disease with elevated intraocular pressure: the closure (mydriatic effect, which leads to an increase in intraocular pressure, can cause acute attack) and open-angle glaucoma (mydriatic effect may cause a slight increase in intraocular pressure may need correction of therapy), age over 40 years (risk of manifestation of undiagnosed glaucoma); – Ulcerative colitis (high doses may suppress intestinal motility, increasing the likelihood of paralytic ileus, in addition, it may be a manifestation or exacerbation of severe complications such as toxic megacolon); – dry mouth (prolonged use may induce further enhancement of expression of xerostomia); – hepatic failure (reduction of metabolism) and renal failure (risk of side effects due to decreased excretion); – chronic lung disease, particularly in debilitated patients (decrease bronchial secretion can lead to condensation and formation of secretions in the bronchi slugging); – myasthenia gravis (a condition may deteriorate due to the inhibition of acetylcholine action); – vegetative (autonomic) neuropathy (urinary retention and accommodation paralysis can be amplified), prostatic hyperplasia without urinary tract obstruction, urinary retention or predisposition thereto or diseases accompanied by obstruction of the urinary tract (including bladder neck due to prostatic hyperplasia ); – preeclampsia (may increase blood pressure); – Down syndrome (perhaps unusual dilated pupils and increased heart rate); – thyrotoxicosis and thyroid diseases (in violation of its functions); – alcoholism.
Dosage
2 mg
Indications
Smooth muscle spasm of the internal organs, peptic ulcer and 12 duodenal ulcer, chronic gastritis, biliary, renal and hepatic colic, hypersecretion salivary and bronchial glands premedication before surgery to reduce the secretion of salivary and bronchial glands, spontaneous abortion prevention of preterm delivery.
Interaction with other drugs
It enhances the effects of other drugs with m-anticholinergic activity.
Overdose
Symptoms: increased anticholinergic effects, atrial fibrillation. Treatment: the use of cholinesterase inhibitors.
pharmachologic effect
Pharmacological group:
M-holinoblokator.
Pharmacodynamics:
Metacin advantageously has a blocking effect on peripheral m- cholinergic receptors, reduces smooth muscle tone of the internal organs, reduces the secretion of the glands of the gastrointestinal tract (GIT), bronchial and sweat glands, increases the heart rate (HR), the conductivity improves atrioventricular (AV). Compared with atropine, causes less mydriasis, accommodation paralysis, and increased intraocular pressure.
Pharmacokinetics:
Monochetvertichnym is an ammonium base, does not penetrate the blood-brain barrier (BBB) ​​(devoid of central action). With barely penetrates gematooftalmologichesky barrier. In oral use is poorly absorbed.
Pregnancy and breast-feeding
Appoint metatsin during pregnancy (except for the prevention of miscarriage or premature birth) is not recommended.
If necessary, the appointment during lactation should stop breastfeeding.
Conditions of supply of pharmacies
On prescription.
side effects
Dry mouth, tachycardia, thirst, dysphagia, constipation, urinary retention, mydriasis, accommodation paralysis, increased intraocular pressure.
special instructions
When side effects should increase the interval between injections or decrease the dose.
Impact on the ability to drive vehicles and mechanisms
It is not recommended during treatment with control vehicle or operating machinery.
Storage conditions
In a dry, dark place at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
Inside before meals 2-4 mg (1-2 tablets), 2 – 3 times a day. The maximum single dose is 5 mg daily – 15 mg.
The course of treatment for 2-4 weeks.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist